Invernizzi, Pietro

Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult‐to‐treat primary biliary cholangitis

Soret, P., Lam, L., Carrat, F., Smets, L., Berg, T., Carbone, M., Invernizzi, P., Leroy, V., Trivedi, P., Cazzagon, N., et al. (2021) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 78

Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut‐Off Approach

Cristoferi, L., Calvaruso, V., Overi, D., Viganò, M., Rigamonti, C., Degasperi, E., Cardinale, V., Labanca, S., Zucchini, N., Fichera, A., et al. (2021) · Hepatology

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 69

The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities

Binatti, E., Gerussi, A., Barisani, D., & Invernizzi, P. (2022) · International Journal of Molecular Sciences

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 62

A functional characteristic of cysteine‐rich protein 61: Modulation of myeloid‐derived suppressor cells in liver inflammation

Zhang, H., Lian, M., Zhang, J., Bian, Z., Tang, R., Miao, Q., Peng, Y., Fang, J., You, Z., Invernizzi, P., et al. (2018) · Hepatology

Liver Diseases and ImmunityImmune cells in cancer

Cited by 61

The liver as a central "hub" of the immune system: pathophysiological implications

Ronca, V., Gerussi, A., Collins, P., Parente, A., Oo, Y. H., & Invernizzi, P. (2025) · Physiological Reviews

Liver Diseases and ImmunityLiver physiology and pathology

Cited by 59

X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

Asselta, R., Paraboschi, E. M., Gerussi, A., Cordell, H. J., Mells, G. F., Sandford, R. N., Jones, D. E., Nakamura, M., Ueno, K., Hitomi, Y., et al. (2021) · Gastroenterology

Liver Diseases and ImmunityGenetic Associations and Epidemiology

Cited by 55

Genetics and epigenetics of primary biliary cirrhosis

Bianchi, I., Carbone, M., Lleo, A., & Invernizzi, P. (2014) · Seminars in Liver Disease

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 45

E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants

Yang, Y., Choi, J., Chen, Y., Invernizzi, P., Yang, G., Zhang, W., Shao, T., Jordan, F., Nemeria, N. S., Coppel, R. L., et al. (2022) · Hepatology

Liver Diseases and ImmunitySystemic Lupus Erythematosus Research

Cited by 44

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., et al. (2015) · Clinics and Research in Hepatology and Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 43

The immunobiology of female predominance in primary biliary cholangitis

Gerussi, A., Cristoferi, L., Carbone, M., Asselta, R., & Invernizzi, P. (2018) · Journal of Autoimmunity

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 41

Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one‐year non‐responders and predicts survival

Murillo Perez, C. F., Ioannou, S., Hassanally, I., Trivedi, P. J., Corpechot, C., van der Meer, A. J., Lammers, W. J., Battezzati, P. M., Lindor, K. D., Nevens, F., et al. (2023) · Liver International

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 39

Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial

Jones, D., Carbone, M., Invernizzi, P., Little, N., Nevens, F., Swain, M. G., Wiesel, P., & Levy, C. (2023) · Hepatology Communications

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 37

Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody–positive versus antimitochondrial autoantibody–negative primary biliary cirrhosis

Jin, Q., Moritoki, Y., Lleo, A., Tsuneyama, K., Invernizzi, P., Moritoki, H., Kikuchi, K., Lian, Z.-X., Hirschfield, G. M., Ansari, A. A., et al. (2012) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 37

Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature

Invernizzi, P., Alessio, M. G., Smyk, D. S., Lleo, A., Sonzogni, A., Fabris, L., Candusso, M., Bogdanos, D. P., Iorio, R., & Torre, G. (2012) · BMC Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 28

Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison

Montali, L., Gragnano, A., Miglioretti, M., Frigerio, A., Vecchio, L., Gerussi, A., Cristoferi, L., Ronca, V., D’Amato, D., O’Donnell, S. E., et al. (2021) · Journal of Translational Autoimmunity

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 26

Making Sense of Autoantibodies in Cholestatic Liver Diseases

Marzorati, S., Invernizzi, P., & Lleo, A. (2016) · Clinics in Liver Disease

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 23

Genetics of Primary Biliary Cholangitis

Gerussi, A., Asselta, R., & Invernizzi, P. (2022) · Clinics in Liver Disease

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 18

P1152: a comparative study of pruritus in PBC cohorts from UK, USA and Italy

Hegade, V. S., Mells, G. F., Lammert, C., Juran, B., Lleo, A., Carbone, M., Lazaridis, K., Invernizzi, P., Kendrick, S., Sandford, R., et al. (2015) · Journal of Hepatology

Liver Diseases and ImmunityDermatology and Skin Diseases

Cited by 15

P1184 : Age, bilirubin and albumin, regardless of sex, are the strongest independent predictors of biochemical response and transplantation-free survival in patients with primary biliary cirrhosis

Cheung, A. C., Lammers, W. J., Hirschfield, G. M., Invernizzi, P., Mason, A. L., Ponsioen, C. Y., Floreani, A., Corpechot, C., Mayo, M. J., Pares, A., et al. (2015) · Journal of Hepatology

Liver Diseases and ImmunityLiver Disease and Transplantation

Cited by 12

Erratum: The cumulative effects of known susceptibility variants to predict primary biliary cirrhosis risk

Tang, R., Chen, H., Miao, Q., Bian, Z., Ma, W., Feng, X., Seldin, M. F., Invernizzi, P., Gershwin, M. E., Liao, W., et al. (2015) · Genes & Immunity

Liver Diseases and ImmunityGenetic Associations and Epidemiology

Cited by 8

SAT-171 Advancements in liver biopsy analysis: convolutional neural networks for portal tract segmentation

Cazzaniga, G., L'Imperio, V., Zucchini, N., Cristoferi, L., Pagni, F., Invernizzi, P., Carbone, M., & Gerussi, A. (2024) · Journal of Hepatology

Medical Image Segmentation TechniquesRadiomics and Machine Learning in Medical Imaging

Cited by 1